Karen Schoedel

9PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 02, 2026
An immunocompetent, multifluorescent resource for real-time analysis of osteosarcoma progression, metastasis, and response to therapy.

|Sep 15, 2026
The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells.

|Jun 26, 2026
The Role of AXL Signaling and Mutant Isocitrate Dehydrogenase 1/2 in Conventional Chondrosarcoma.

|Jul 30, 2024
Novel dual gene fusions identified in a late pulmonary metastasis of an infantile fibrosarcoma-like tumor.

Karen Schoedel, Shaymaa Hegazy, Megan L Zilla

|Mar 26, 2024
Postoperative infection and bone sarcoma survival: systematic review of the role of infection in bone sarcoma prognosis.

Sean W Dooley, Matthew F Gong, Luke A Carlson

|Jan 23, 2024
Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy.

Karen Schoedel, Tanya Heim, Anette Duensing

Pageof 2

Frequent Collaborators

2 joint publications

Ines Lohse

2 joint publications

Rana Naous

2 joint publications

Azfar Neyaz

2 joint publications

Kurt Weiss